Matthew Pinto
Family Medicine · Marlton, NJNPI 1326158783
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $216,703 of the $239,417 with a category attached, or 90.5%. AbbVie accounts for 99.7% of it on its own, with 6 other manufacturers making up the rest. Among family medicine clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 447 payments — averaging $535.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$239K
- Novo Nordisk$473
- Galderma Laboratories, L.p.$54
- Vivus LLC$42
- Currax Pharmaceuticals LLC$41
- Antares Pharma, Inc.$31
- plus $30 from 1 others
What the payments were for
- Consulting fees$1,0990%
- Speaking & faculty fees$216,70391%
- Travel & lodging$14,1806%
- Food & beverage$7,4253%
- Education$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 396 | $238,746 |
| Novo Nordisk | 38 | $473 |
| Galderma Laboratories, L.p. | 3 | $54 |
| Vivus LLC | 3 | $42 |
| Currax Pharmaceuticals LLC | 3 | $41 |
| Antares Pharma, Inc. | 2 | $31 |
| Lilly USA, LLC | 2 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$131,891
- KYBELLA$1,950
- BOTOX COSMETIC$148
How this compares
$239,417 in reported general payments places this provider in the 95th percentile of 2,084 family medicine providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 23 | $20,157 |
| Topiramate | 12 | $109 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $473 | $20,15723 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,084 family medicine providers in New Jersey.
Other family medicine in Marlton
- Jay PatelMarlton$25K
- Hetal ShahMarlton$18K
- Mikhail VarshavskiChatham$1.4M
- Janet ColeFar Hills$466K
- Jennifer CaudleSewell$226K
- Jeffrey LevineNew Brunswick$195K
- Jennifer AmicoNew Brunswick$159K
- Dena LacaraFairfield$122K
- Gaurang BrahmbhattHoboken$89K
- Juan LatorreHoboken$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.